Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Key predictors of long-term outcomes in BCMA-targeted CAR-T therapy for relapsed/refractory multiple myeloma

Fig. 3

Univariate and multivariate survival analysis of PFS and OS. (A-D) Forest plots showing hazard ratios for PFS and OS estimated by univariate and multivariate Cox proportional hazards regression outcome analyses. Forest plots showing the association between risk factors and survival in our center. ADA, Anti-drug antibodies; BCMA, B-cell maturation antigen; CAR, chimeric antigen receptor; CR, complete response; EMMR-ISS, Revised International Staging System; HR, hazard ratio; MRD, minimal residual disease; OS, overall survival; PFS, progression-free survival; SCT, stem cell transplantation; sBCMA, Plasma levels of soluble BCMA

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us